| Reporting Organization: | PRE-EMPT |
|---|---|
| Total Budget ($CAD): | $ 33,863,873 |
| Timeframe: | November 15, 2011 - June 14, 2019 |
| Status: | Implementation |
| Contact Information: |
Marianne Vidler [email protected] |
| India - $ 11,290,215.09 (33.34%) | |
|
|
|
| Mozambique - $ 11,286,828.70 (33.33%) | |
|
|
|
| Pakistan - $ 11,286,828.70 (33.33%) | |
|
|
|
| Reproductive Health & Rights incl. Maternal Health (50 %) | |
|
|
|
| Health Systems, Training & Infrastructure (20 %) | |
|
|
|
| Health Promotion & Education (10 %) | |
|
|
|
| Primary Health Care (10 %) | |
|
|
|
| Secondary/Tertiary Health Care (10 %) | |
|
|
|
We are a global consortium of researchers, innovators, & advocates who work in diverse areas ranging from clinical medicine, data & social science, epidemiology, biobanking, medical anthropology, & health policy with the aim of improving maternal health.
| Gender and age: | Adult women |
|---|---|
| Descriptors: | Rural |
| Total Direct Population: | 69,350 |
| 295 | Abstracts and papers published |
| 7 | Annual reports produced |
Unspecified
Objective 1: Prevention (the CAP or the Calcium and Pre-eclampsia Trial) – found that low-dose calcium probably reduces risk of recurrent
pre-eclampsia and pregnancy loss
Objective 2: Monitoring (miniPIERS and PIERS On the Move) – Accurate time-of-disease risk stratification, detected 2081 hypertensive pregnant women
Objective 3: Treatment (Gynuity Oral Antihypertensive Project and the Community Level Interventions for Pre-eclampsia Trial)
Detected 894 women with severe pregnancy hypertension and found Nifedipine, Labetalol and Methyldopa largely equivalent.
Objective 4: Global Pregnancy Collaboration – 24 Centres providing samples, access to >450,000 samples
Objective 5: Knowledge Translation – 23,106 community engagement sessions during CLIP Trials and 589 health workers trained
